Last of Zymergen’s 3 founders to leave as synbio company preps for merger with 80 more layoffs

Chief Scientific Officer Zach Serber, former operations chief Jed Dean and former CEO Josh Hoffman took Zymergen from an April 2013 startup to an 800-employee company with a $525 million 2021 IPO before it imploded a year ago.